Practice
Specialties
Hygiene
Clinical
Business
Cases
Careers
Tariffs
Sign In
Fluoride
Hygiene Tools
Infection Control
Nutrition
Oral-Systemic Link
Scope of Practice
Oral Cancer: Page 17
How do oral disorders affect your patients' lives?
By
Tony Edwards
When patients come to your office with oral lichen planus, actinic keratosis, erythroplakia, or another oral potentially malignant disorder, they may be experiencing physical and psychological distress in addition to pain. A new study examined how these disorders can affect patients' lives.
April 17, 2017
CDC: 4% of U.S. adults have high-risk oral HPV
By
DrBicuspid.com staff writers
New data from the U.S. Centers for Disease Control and Prevention (CDC) show that 4% of all U.S. adults ages 18 to 69 have a form of HPV that puts them at an increased risk for head and neck cancers.
April 9, 2017
Are e-cigarettes more harmful than regular cigarettes?
By
Lori Roniger
Electronic cigarettes have been touted by some as being safer than regular cigarettes. However, research presented at the recent International Association for Dental Research (IADR) annual meeting links e-cigarette use with potentially harmful microbiome changes and the risk of periodontal disease.
March 30, 2017
Survey: Only 29% of patients screened for oral cancer
By
DrBicuspid.com staff writers
Only 29% of U.S. patients reported being screened for oral cancer at their last visit to the dental office, according to a new survey released by the Oral Cancer Foundation, the Head and Neck Cancer Alliance, Vigilant Biosciences, and Support for People with Oral and Head and Neck Cancer.
March 30, 2017
2017 Dental Excellence Award winners honored
By
Tony Edwards
CHICAGO - On the exhibit floor at the 2017 Chicago Dental Society Midwinter Meeting,
DrBicuspid.com
honored the winners of the 2017 Dental Excellence Awards.
February 23, 2017
Oral cancer cases in men projected to increase in 2017
By
Brian Casey
,
DrBicuspid.com staff writers
The number of new cases of cancer of the oral cavity and pharynx in men is expected to increase to more than 35,000 in the U.S. in 2017, according to a report on cancer mortality published by the American Cancer Society. The number of new cases of these cancers in women is expected to remain around 14,000.
January 8, 2017
Oral cancer cases in men projected to increase in 2017
By
Brian Casey
,
DrBicuspid.com staff writers
The number of new cases of cancers of the oral cavity and pharynx in men is expected to increase to more than 35,000 in the U.S. in 2017, according to a report on cancer mortality published by the American Cancer Society. The number of new cases of these cancers in women is expected to remain around 14,000.
January 8, 2017
DrBicuspid.com Dental Excellence Awards 2016 finalists
By
Tony Edwards
DrBicuspid.com
is pleased to announce the finalists chosen by our readers for the 2016 Dental Excellence Awards. We want to thank the hundreds of readers who participated in the voting.
December 11, 2016
Cellceutix reports increased net loss for 2017 Q1
By
DrBicuspid.com staff writers
Biopharmaceutical company Cellceutix has reported an increased net loss for its first quarter of fiscal year 2017.
November 16, 2016
CDC: Fewer U.S. adults smoke now than in 2005
By
Tony Edwards
Does your patient population include adults ages 25 to 44 who didn't graduate from high school or earned a GED certificate? If so, these are your patients who are most likely to smoke cigarettes, according to a new report from the Centers for Disease Control and Prevention (CDC). The good news is that the number of adult smokers has declined since 2005.
November 14, 2016
Dental school provides free checkups for and by vets
By
Theresa Pablos
One California dental school celebrated Veterans Day by providing free oral health checkups for veterans. Several of the volunteers who conducted the screenings are attending dental school on military scholarships or are veterans themselves.
November 14, 2016
Head/neck cancer treatment gets FDA approval
By
DrBicuspid.com staff writers
Bristol-Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has approved its Opdivo intravenous injection for patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
November 10, 2016
Previous Page
Page 17 of 116
Next Page